Compare Vyzulta and Rhopressa to Other Glaucoma Meds

May 2018

New Rx Vyzulta (latanoprostene bunod) and Rhopressa (netarsudil) will lead to questions about how meds for open-angle glaucoma compare.

Patients often get one glaucoma med to start...then meds are switched or added from other classes until intraocular pressure is controlled. These meds lower pressure by increasing fluid outflow or decreasing fluid production.

Be prepared to address patient questions about these meds.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Antithrombotics Consider a Blended Approach to VTE Prophylaxis After Hip or Knee Replacement
Hypertension Fine-Tune BP Goals and Meds for Patients With Diabetes
HIV & AIDS Help Reduce HIV Risk With Pre-Exposure Prophylaxis for HIV
Appropriate Med Use Look for Meds That Can Come Off Most Med Lists
Renal & Urology Don't Jump to the New Desmopressin Nasal Spray (Noctiva) for Nocturia
Glaucoma Compare Vyzulta and Rhopressa to Other Glaucoma Meds
Ophthalmology Help Patients Avoid Common Eye Drop Errors
Pregnancy Ease Nausea and Vomiting Associated With Pregnancy
Practice Be Familiar With Nuances of REMS Requirements
Inhalers Match Inhaler Devices to Your Patient's Abilities

Compare Vyzulta and Rhopressa to Other Glaucoma Meds

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents